Skip to main navigation
  • About Stoke
    • Leadership
  • Our Science
    • Tango
    • Publications
    • Founders
  • Disease Areas
    • Dravet Syndrome
    • ADOA
  • Pipeline
    • Clinical Studies
  • Careers
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
Stoke Therapeutics
  • Contact Us
  • LinkedIn
  • Twitter
  • About Stoke
    • Leadership
  • Our Science
    • Tango
    • Publications
    • Founders
  • Disease Areas
    • Dravet Syndrome
    • ADOA
  • Pipeline
    • Clinical Studies
  • Careers
  • Investors & News
    • Overview
    • Media Room
    • Press Releases
    • Events & Presentations
    • Financials & SEC Filings
    • Stock Information
    • Analyst Coverage
    • Governance
  • Home
  • Investors & News
  • Financials & SEC Filings
  • SEC Filing Details

SEC Filing Details

Document Details

Form
10-Q
Filing Date
August 8, 2022
Document Date
June 30, 2022
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Stoke Therapeutics
Issuer
Stoke Therapeutics, Inc.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
XML - XBRL INSTANCE DOCUMENT
Print Page
Email Alerts
Contact IR
Investor FAQs
  • About Us
  • Our Science
  • Disease Areas
  • Pipeline
  • Careers
  • Investors & News
  • Contact Us
Stoke Logo

© 2023 Stoke Therapeutics, all rights reserved.

  • Privacy Policy
  • Terms of Use
  • Site Map
  • LinkedIn
  • Twitter